Semaglutide begins here with a US FDA medicine identity.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Semaglutide begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in the Philippines. Verify the exact local records below.
Resolve the exact identity of Semaglutide through Current WEGOVY prescribing information from National Library of Medicine, DailyMed. Then search FDA Verification Portal from Food and Drug Administration Philippines for the destination product record and FDA advisory on Verification Portal use from Food and Drug Administration Philippines for the seller, establishment, or supply route in Philippines. A match in one record does not replace the other two checks.
No. A page using the name Semaglutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. Semaglutide is the active ingredient in several distinct prescription products. WEGOVY has product-specific authorizations in the United States and European Union, and Canada authorized generic semaglutide products in 2026. Those records do not make every semaglutide offer, compounded product, imported package, brand, indication, presentation, or seller equivalent or authorized in every country. For Philippines, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
Semaglutide begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in the Philippines. Verify the exact local records below.
Primary identity source: Current WEGOVY prescribing information / National Library of Medicine, DailyMed ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Current WEGOVY prescribing information is maintained by National Library of Medicine, DailyMed. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Current WEGOVY prescribing information ↗FDA Verification Portal is maintained by Food and Drug Administration Philippines. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open FDA Verification Portal ↗FDA advisory on Verification Portal use is maintained by Food and Drug Administration Philippines. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open FDA advisory on Verification Portal use ↗Philippine search results can combine clinics, wellness services, imported products, marketplace listings, research materials, and medicine claims. The FDA portal separates a product's CPR or notification record from the establishment's License to Operate.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use the FDA Verification Portal's registered-health-product records for the precise product, certificate, holder, and category. A matching ingredient or foreign approval is not the same Philippine record.
Use the licensed-establishment records to match the legal name and relevant License to Operate to the business presenting the offer. A product result does not verify every seller using that name.
Treat the portal as a verification tool rather than regulatory advice, and use the FDA correction process if the current entry appears inconsistent or incomplete.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.